No Data
No Data
Lyell Immunopharma Shares Are Trading Higher After the Company Announced That Three Abstracts Highlighting Its Pipeline of Clinical Product Candidates and Anti-exhaustion Technology Have Been Accepted for Presentation at the 39th Annual Meeting of the...
Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Lyell Immunopharma Announces Participation in September Investor Conferences
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins FuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
HC Wainwright & Co. Reiterates Neutral on Lyell Immunopharma, Maintains $1 Price Target
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Lyell Immunopharma (LYEL) and Janux Therapeutics Inc (JANX)